US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 3.540
  • -0.285-7.45%
Close May 22 16:00 ET
  • 3.550
  • +0.010+0.28%
Post 19:39 ET
127.63MMarket Cap-2391P/E (TTM)

scPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
195.78%6.1M
13.59M
6.1M
3.8M
1.64M
2.06M
0
0
0
0
Operating revenue
195.78%6.1M
--13.59M
--6.1M
--3.8M
--1.64M
--2.06M
--0
--0
--0
--0
Cost of revenue
195.04%1.79M
3.81M
1.77M
1.08M
354K
605K
0
0
0
0
Gross profit
196.09%4.32M
9.78M
4.32M
2.72M
1.28M
1.46M
0
0
0
0
Operating expense
55.03%20.17M
80.26%65.18M
106.06%19.58M
75.65%17.56M
59.54%15.03M
79.72%13.01M
40.02%36.16M
41.38%9.5M
69.26%10M
45.93%9.42M
Selling and administrative expenses
60.12%17.45M
158.77%53.37M
126.34%16.24M
125.19%14.14M
182.68%12.1M
276.63%10.9M
110.79%20.62M
227.52%7.18M
183.90%6.28M
61.53%4.28M
-General and administrative expense
----
158.77%53.37M
----
----
----
----
110.79%20.62M
----
----
----
Research and development costs
28.83%2.73M
-23.97%11.81M
43.51%3.34M
-7.99%3.42M
-42.94%2.93M
-51.32%2.12M
-3.15%15.53M
-48.65%2.33M
0.65%3.72M
35.07%5.14M
Operating profit
-37.23%-15.86M
-53.21%-55.4M
-60.57%-15.26M
-48.46%-14.84M
-45.91%-13.75M
-59.59%-11.55M
-40.02%-36.16M
-41.38%-9.5M
-69.26%-10M
-45.93%-9.42M
Net non-operating interest income expense
-89.47%-1.22M
-43.83%-3.02M
12.80%-967K
-423.45%-759K
-90.29%-647K
-27.92%-646K
16.90%-2.1M
-80.62%-1.11M
77.93%-145K
46.79%-340K
Non-operating interest income
-33.31%877K
324.27%5.1M
32.35%1.13M
460.78%1.3M
1,173.83%1.36M
10,015.38%1.32M
2,355.10%1.2M
12,042.86%850K
2,220.00%232K
791.67%107K
Non-operating interest expense
7.14%2.1M
146.00%8.12M
6.79%2.09M
446.42%2.06M
349.66%2.01M
278.57%1.96M
28.23%3.3M
215.46%1.96M
-43.48%377K
-31.34%447K
Other net income (expense)
200.20%2.97M
154.23%3.61M
76.96%2.41M
-63.64%-36K
273.44%239K
6,971.43%990K
350.16%1.42M
7,917.65%1.36M
-320.00%-22K
93.94%64K
Other non- operating income (expenses)
200.20%2.97M
154.23%3.61M
76.96%2.41M
-63.64%-36K
273.44%239K
6,971.43%990K
350.16%1.42M
7,917.65%1.36M
-320.00%-22K
93.94%64K
Income before tax
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
-37.31%-9.7M
Income tax
Net income
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
-37.31%-9.7M
Net income continuous Operations
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
-37.31%-9.7M
Minority interest income
Net income attributable to the parent company
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
-37.31%-9.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
-37.31%-9.7M
Basic earnings per share
-20.00%-0.36
-9.23%-1.42
-16.67%-0.35
-10.81%-0.41
-2.86%-0.36
-7.14%-0.3
-27.45%-1.3
-11.11%-0.3
-54.17%-0.37
-34.62%-0.35
Diluted earnings per share
-20.00%-0.36
-9.23%-1.42
-16.67%-0.35
-10.81%-0.41
-2.86%-0.36
-7.14%-0.3
-27.45%-1.3
-11.11%-0.3
-54.17%-0.37
-34.62%-0.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 195.78%6.1M13.59M6.1M3.8M1.64M2.06M0000
Operating revenue 195.78%6.1M--13.59M--6.1M--3.8M--1.64M--2.06M--0--0--0--0
Cost of revenue 195.04%1.79M3.81M1.77M1.08M354K605K0000
Gross profit 196.09%4.32M9.78M4.32M2.72M1.28M1.46M0000
Operating expense 55.03%20.17M80.26%65.18M106.06%19.58M75.65%17.56M59.54%15.03M79.72%13.01M40.02%36.16M41.38%9.5M69.26%10M45.93%9.42M
Selling and administrative expenses 60.12%17.45M158.77%53.37M126.34%16.24M125.19%14.14M182.68%12.1M276.63%10.9M110.79%20.62M227.52%7.18M183.90%6.28M61.53%4.28M
-General and administrative expense ----158.77%53.37M----------------110.79%20.62M------------
Research and development costs 28.83%2.73M-23.97%11.81M43.51%3.34M-7.99%3.42M-42.94%2.93M-51.32%2.12M-3.15%15.53M-48.65%2.33M0.65%3.72M35.07%5.14M
Operating profit -37.23%-15.86M-53.21%-55.4M-60.57%-15.26M-48.46%-14.84M-45.91%-13.75M-59.59%-11.55M-40.02%-36.16M-41.38%-9.5M-69.26%-10M-45.93%-9.42M
Net non-operating interest income expense -89.47%-1.22M-43.83%-3.02M12.80%-967K-423.45%-759K-90.29%-647K-27.92%-646K16.90%-2.1M-80.62%-1.11M77.93%-145K46.79%-340K
Non-operating interest income -33.31%877K324.27%5.1M32.35%1.13M460.78%1.3M1,173.83%1.36M10,015.38%1.32M2,355.10%1.2M12,042.86%850K2,220.00%232K791.67%107K
Non-operating interest expense 7.14%2.1M146.00%8.12M6.79%2.09M446.42%2.06M349.66%2.01M278.57%1.96M28.23%3.3M215.46%1.96M-43.48%377K-31.34%447K
Other net income (expense) 200.20%2.97M154.23%3.61M76.96%2.41M-63.64%-36K273.44%239K6,971.43%990K350.16%1.42M7,917.65%1.36M-320.00%-22K93.94%64K
Other non- operating income (expenses) 200.20%2.97M154.23%3.61M76.96%2.41M-63.64%-36K273.44%239K6,971.43%990K350.16%1.42M7,917.65%1.36M-320.00%-22K93.94%64K
Income before tax -25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M-37.31%-9.7M
Income tax
Net income -25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M-37.31%-9.7M
Net income continuous Operations -25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M-37.31%-9.7M
Minority interest income
Net income attributable to the parent company -25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M-37.31%-9.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M-37.31%-9.7M
Basic earnings per share -20.00%-0.36-9.23%-1.42-16.67%-0.35-10.81%-0.41-2.86%-0.36-7.14%-0.3-27.45%-1.3-11.11%-0.3-54.17%-0.37-34.62%-0.35
Diluted earnings per share -20.00%-0.36-9.23%-1.42-16.67%-0.35-10.81%-0.41-2.86%-0.36-7.14%-0.3-27.45%-1.3-11.11%-0.3-54.17%-0.37-34.62%-0.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg